Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Durberg Meds AB
AB
Active
Org 5593901134
Stampgatan 56 C, 411 01
Göteborg
General medical practice activities
·
NACE 8621
Est. 2022 · 4 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Durberg Meds AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2023: 2M
2M
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 1M (-50% vs 2024)
1M
-50%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
Revenue
798
1 559
1 889
Staff expenses
−273
−367
−115
EBITDA
70
649
1 342
Depreciation & amort.
−5
—
—
EBIT
65
649
1 342
Net financials
197
57
1
Profit before tax
261
706
1 343
Tax
−41
−141
−279
Net profit
220
565
1 064
Balance sheet
SEK thousands
Item
2025
2024
2023
Total assets
1 067
1 459
1 368
Equity
380
959
1 089
Long-term debt
—
—
—
Short-term debt
687
499
279
Total debt
687
499
279
Financial ratios
5-year trend
EBITDA margin
8,7 %
This company
15,8 %
Market median
This company
Market median
45% below market
2023
2025
Equity ratio
35,6 %
This company
38,2 %
Market median
This company
Market median
7% below market
2023
2025
Return on equity
58,0 %
This company
18,4 %
Market median
This company
Market median
215% above market
2023
2025
Net profit margin
27,6 %
This company
8,1 %
Market median
This company
Market median
241% above market
2023
2025
Asset turnover
0,75×
This company
1,12×
Market median
This company
Market median
33% below market
2023
2025
Debt / equity
1,81×
This company
0,62×
Market median
This company
Market median
192% above market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-18 – 2023-08-31
View
PDF
More on Durberg Meds AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
